Evaluation of the Safety, Tolerability and Immunogenicity of VARIVAX ™ in Healthy Russians (V210-058)
Condition: Varicella Intervention: Biological: VARIVAX™ Sponsor: Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials